CNTA Stock Analysis: Buy, Sell, or Hold?
CNTA - Centessa Pharmaceuticals plc American Depositary Shares
$39.70
-0.02 (-0.06%)
▼
5d:
+40.66%
30d:
+51.51%
90d:
+60.45%
WAIT
LOW Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 18, 2026
Get Alerted When CNTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CNTA is 26.0% above fair value ($31.51). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CNTA is 26.0% above fair value ($31.51). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CNTA is currently trading at $39.70, which is considered extended relative to its 30-day fair value range of $24.79 to $31.51.
Technical Outlook: Technically, CNTA is showing sideways momentum. The price is approaching resistance at $40.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNTA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNTA is showing sideways momentum. The price is approaching resistance at $40.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNTA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$24.79 -
$31.51
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+26.0% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($40.38)
- WARNING: Recommendation downgraded due to 26.0% overvaluation
Fair Price Analysis
30-Day Fair Range
$24.79 -
$31.51
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$25.17
Resistance Level
$40.26
Current Trend
Sideways
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-24.16
Wall Street Target
$40.38
(+1.7%)
Share & Embed Analysis
Last updated: April 01, 2026 2:36 PM ET
Data refreshes hourly during market hours. Next update: 3:36 PM
Data refreshes hourly during market hours. Next update: 3:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Karen M Anderson
SELL
10043 shares
2026-03-17
Karen M Anderson
SELL
64768 shares
2026-03-16
Karen M Anderson
SELL
120029 shares
2026-03-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 66 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 57 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$100 | 57 HOLD |
